A simple mathematical model for relapsing-remitting multiple sclerosis (RRMS)

被引：10
|
作者：
Elettreby, M. F. [1 ,2 ]
Ahmed, E. [2 ]
机构：
[1] King Khalid Univ, Fac Sci, Math Dept, Abha 9004, Saudi Arabia
[2] Mansoura Univ, Fac Sci, Math Dept, Mansoura 35516, Egypt
来源：
MEDICAL HYPOTHESES | 2020年 / 135卷
关键词：
Multiple sclerosis; Relapse; Recurrence; Autoimmune diseases; Complex system; MATTER VOLUME; LYMPHOCYTES; CYTOKINES; BRAIN; GREY;
D O I：
10.1016/j.mehy.2019.109478
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Multiple sclerosis is one of the most common autoimmune-related neurological disorders affecting the central nervous system. One of its main properties is dissemination of lesions in time and space. Here, we propose a simple mathematical model to describe the stages of disease progression with recurrence. We tried to find the steady states and evaluated their stability to identify the necessary conditions to produce the recurrence. Also, we described the analytical results with some numerical simulations.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Resistance Training in Relapsing-Remitting Multiple Sclerosis
    Dalgas, U.
    Kant, M.
    Stenager, E.
    AKTUELLE NEUROLOGIE, 2010, 37 (05) : 213 - 218
  • [42] Cognitive Resilience in Relapsing-Remitting Multiple Sclerosis
    Achiron, Anat
    Harel, Yermi
    Lavie, Mor
    Simon, Ely S.
    Doniger, Glen M.
    NEUROLOGY, 2010, 74 (09) : A162 - A162
  • [43] Relapsing-remitting multiple sclerosis and subclinical atherosclerosis
    Omerzu, T.
    Magdic, J.
    Hojs, R.
    Fabjan, T. Hojs
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 376 - 377
  • [44] An update on cladribine for relapsing-remitting multiple sclerosis
    Holmoy, Trygve
    Torkildsen, Oivind
    Myhr, Kjell-Morten
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1627 - 1635
  • [45] Therapeutic inertia in relapsing-remitting multiple sclerosis
    Rodrigues, Rita
    Rocha, Raquel
    Bonifacio, Goncalo
    Ferro, Daniela
    Sabenca, Francisco
    Goncalves, Ana Isabel
    Correia, Filipe
    Pinheiro, Joaquim
    Loureiro, Jose Leal
    Guerreiro, Rui Pedro
    Vale, Jose
    Sa, Maria Jose
    Costa, Andreia
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 55
  • [46] A CASE OF RELAPSING-REMITTING TUMEFACTIVE MULTIPLE SCLEROSIS
    Turnbull, H.
    Karsan, N.
    Hogg, F.
    Pereira, A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83
  • [47] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
    Herwerth, Marina
    Hemmer, Bernhard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
  • [48] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
    Menge, Til
    Dubey, Divyanshu
    Warnke, Clemens
    Hartung, Hans-Peter
    Stuve, Olaf
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
  • [49] Development of laquinimod for relapsing-remitting multiple sclerosis
    Jeffery, Douglas R.
    FUTURE NEUROLOGY, 2008, 3 (06) : 641 - 648
  • [50] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Hersh, Carrie M.
    Cohen, Jeffrey A.
    IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
12345